Showing results (1-10 of 11) with videos related to

Sort By:
Pageof 2
Frontiers in Immunology|May 22, 2020
A Brief Review of the Effects of Vitamin D on Multiple SclerosisAndrei Miclea, Maud Bagnoud, Andrew Chan, et al.
Therapeutic Advances in Neurological Disorders|July 2, 2021
An algorithm using clinical data to predict the optimal individual glucocorticoid dosage to treat multiple sclerosis relapsesJudit Gili-Kovács, Robert Hoepner, Anke Salmen, et al.
Therapeutic Advances in Neurological Disorders|May 21, 2019
Time course of lymphocyte repopulation after dimethyl fumarate-induced grade 3 lymphopenia: contribution of patient ageMyriam Briner, Maud Bagnoud, Andrei Miclea, et al.
Cells|September 28, 2023
In Vivo and In Vitro Evidence for an Interplay between the Glucocorticoid Receptor and the Vitamin D Receptor SignalingMaud Bagnoud, Jana Remlinger, Marine Massy, et al.
Cells|September 26, 2020
c-Jun N-Terminal Kinase as a Therapeutic Target in Experimental Autoimmune EncephalomyelitisMaud Bagnoud, Myriam Briner, Jana Remlinger, et al.
CNS Neuroscience & Therapeutics|October 11, 2023
Predicting glucocorticoid resistance in multiple sclerosis relapse via a whole blood transcriptomic analysisMaud Bagnoud, Jana Remlinger, Sandrine Joly, et al.
Neurology(R) Neuroimmunology & Neuroinflammation|July 10, 2023
Modeling MOG Antibody-Associated Disorder and Neuromyelitis Optica Spectrum Disorder in Animal Models: Visual System ManifestationsJana Remlinger, Maud Bagnoud, Ivo Meli, et al.
Multiple Sclerosis and Related Disorders|July 27, 2023
Modelling MOG antibody-associated disorder and neuromyelitis optica spectrum disorder in animal models: Spinal cord manifestationsJana Remlinger, Maud Bagnoud, Ivo Meli, et al.
Neurology(R) Neuroimmunology & Neuroinflammation|January 14, 2022
Antineonatal Fc Receptor Antibody Treatment Ameliorates MOG-IgG-Associated Experimental Autoimmune EncephalomyelitisJana Remlinger, Adrian Madarasz, Kirsten Guse, et al.
Therapeutic Advances in Neurological Disorders|October 22, 2019
Reduced serum immunoglobulin G concentrations in multiple sclerosis: prevalence and association with disease-modifying therapy and disease courseGreta Zoehner, Andrei Miclea, Anke Salmen, et al.
Pageof 2